Publication:

Tuning the Functional Properties of Nanocarriers Using Tunable Nano-Biointerfaces

Date

 
cris.virtual.department#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.orcid0000-0002-2264-2536
cris.virtualsource.departmentde48631c-19f8-4694-a94c-ceb8c31802d2
cris.virtualsource.orcidde48631c-19f8-4694-a94c-ceb8c31802d2
dc.contributor.authorPancaro, Alessia
dc.contributor.authorMailaender, Volker
dc.contributor.authorLandfester, Katharina
dc.contributor.authorEthirajan, Anitha
dc.contributor.imecauthorPancaro, Alessia
dc.contributor.imecauthorEthirajan, Anitha
dc.contributor.orcidimecEthirajan, Anitha::0000-0002-2264-2536
dc.date.accessioned2025-06-06T04:50:09Z
dc.date.available2025-06-06T04:50:09Z
dc.date.issued2026
dc.description.abstractTuning the functional properties of nanocarriers has gained increasing interest in recent years as a key strategy to accelerate the clinical translation of nanomedicine. Once nanocarriers come into contact with a biological fluid such as blood, interactions occur at the nanocarrier/biological fluid interface that alter the identity of the nanocarriers. As knowledge in this field is rapidly evolving, this review highlights some of the latest developments (2021 to early 2025) and covers the significant findings in the field of the nano-biointerface. Specifically, the current obstacles in achieving the goal of targeting are addressed with emphasis on the formation and impact of the adsorbed proteins, the so-called protein corona. The strategies to overcome these obstacles are explored by rational design of nanocarriers using biomimetic coatings (proteins and membranes) to enhance favorable interactions between nanocarriers and biological systems. The challenges in the current strategies such as problems related to the gold standard (poly(ethylene glycol)ylation), availability for targeting proteins (functionalization, structural integrity), etc., and current alternatives to overcome the obstacles are discussed. Finally, some future perspectives are discussed to facilitate the clinical translation of nanomedicine.
dc.description.wosFundingTextA.P. is a Postdoctoral Fellow of the Research Foundation Flanders (FWO Project No. 12AR624N).
dc.identifier.doi10.1002/adfm.202508121
dc.identifier.issn1616-301X
dc.identifier.urihttps://imec-publications.be/handle/20.500.12860/45759
dc.publisherWILEY-V C H VERLAG GMBH
dc.source.beginpage250821
dc.source.issue20
dc.source.journalADVANCED FUNCTIONAL MATERIALS
dc.source.numberofpages26
dc.source.volume36
dc.subject.keywordsANTI-PEG ANTIBODIES
dc.subject.keywordsCELL-DERIVED NANOCARRIERS
dc.subject.keywordsPROTEIN CORONA
dc.subject.keywordsEXTRACELLULAR VESICLES
dc.subject.keywordsCOMPLEMENT ACTIVATION
dc.subject.keywordsTARGETED DELIVERY
dc.subject.keywordsENGINEERED EXOSOMES
dc.subject.keywordsBIOLOGICAL IDENTITY
dc.subject.keywordsALLERGIC REACTIONS
dc.subject.keywordsMESSENGER-RNA
dc.title

Tuning the Functional Properties of Nanocarriers Using Tunable Nano-Biointerfaces

dc.typeJournal article review
dspace.entity.typePublication
Files
Publication available in collections: